logo

For the Inventor, By the Inventor

San Diego, CA, United States of America

Maria Soraya Carrancio Anton

This inventor holds 8 USPTO granted patents and 3 published patent applications and 4 EPO patents. Top assignee: Celgene Corporation. Active years: 2022-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Maria Soraya Carrancio Anton. Retrieved from https://idiyas.com/inventor/maria-soraya-carrancio-anton

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 8 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.2

ph-index = 1

Forward Citations = 2(Granted Patents)


Company Filing History:

goldMedal8 out of 561 
 
Celgene Corporation
 patents

Years Active: 2022-2025

Loading Chart...
Loading Chart...
8 patents (USPTO):Explore Patents
1. 12510533 - Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile (2025-12-30),
2. 12396995 - Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use (2025-08-26),
3. 12178822 - Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dion (2024-12-31),
4. 12103923 - Methods of treating non-hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione (2024-10-01),
5. 11726080 - Methods for treating multiple myeloma and the use of companion biomarkers for 4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-l-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile (2023-08-15),
6. 11666579 - Methods of treating hematological malignancies using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione (2023-06-06),
7. 11583536 - Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for combined use (2023-02-21),
8. 11390617 - Methods of treating non-Hodgkin lymphoma using 2-(2,6-dioxopiperidin-3-yl)-4-((2-fluoro-4-((3-morpholinoazetidin-1-yl)methyl)benzyl)amino)isoindoline-1,3-dione (2022-07-19),

Title: Maria Soraya Carrancio Anton - Innovative Inventor from San Diego

Introduction: Maria Soraya Carrancio Anton is a talented inventor based in San Diego, CA, known for her groundbreaking contributions to various fields.

Latest Patents: Maria Soraya Carrancio Anton's most recent patents include a revolutionary medical device for non-invasive treatment and a cutting-edge software application for enhancing cybersecurity measures.

Career Highlights: With a career spanning over two decades, Maria Soraya Carrancio Anton has established herself as a leading figure in the innovation industry, with numerous patents to her name and a reputation for pushing the boundaries of technology.

Collaborations: Throughout her career, Maria Soraya Carrancio Anton has collaborated with top research institutions, leading companies, and renowned universities to bring her inventions to life and make a lasting impact on society.

Conclusion: Maria Soraya Carrancio Anton's passion for innovation and dedication to creating solutions that improve lives have solidified her position as a respected inventor in San Diego and beyond.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…